|
PARP11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.335800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.817900E-02 |
| Normal-vs-Stage2 |
1.169250E-01 |
| Normal-vs-Stage3 |
3.875800E-01 |
| Normal-vs-Stage4 |
8.783200E-01 |
| Stage1-vs-Stage2 |
7.937400E-01 |
| Stage1-vs-Stage3 |
7.694400E-01 |
| Stage1-vs-Stage4 |
3.533400E-01 |
| Stage2-vs-Stage3 |
6.536600E-01 |
| Stage2-vs-Stage4 |
3.043800E-01 |
| Stage3-vs-Stage4 |
5.342800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.351640E-02 |
| Normal-vs-AfricanAmerican |
2.921700E-02 |
| Normal-vs-Asian |
5.504600E-01 |
| Caucasian-vs-AfricanAmerican |
6.248400E-01 |
| Caucasian-vs-Asian |
3.505000E-01 |
| AfricanAmerican-vs-Asian |
2.812600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.751790E-02 |
| Normal-vs-Female |
7.517400E-03 |
| Male-vs-Female |
2.963800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.720800E-01 |
| Normal-vs-Extreme_Weight |
4.533200E-01 |
| Normal-vs-Obese |
6.283700E-03 |
| Normal-vs-Extreme_Obese |
5.805600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.078600E-01 |
| Normal_Weight-vs-Obese |
1.640010E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.533600E-01 |
| Extreme_Weight-vs-Obese |
6.310000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.338400E-01 |
| Obese-vs-Extreme_Obese |
8.371700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.303500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.163500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.162380E-01 |
| Normal-vs-Age(81-100Yrs) |
9.941600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.856600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.700400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.542210E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.606300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.740610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.237400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.615270E-04 |
| Normal-VS-Type2 PRCC |
5.513400E-01 |
| Normal-VS-KIRP CIMP |
6.186800E-01 |
| Normal-VS-Unclassified PRCC |
4.456600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.363800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
7.382000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.041400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.488000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.464200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.049900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.099400E-01 |
| Normal-vs-N1 |
1.136210E-01 |
| Normal-vs-N2 |
2.786000E-01 |
| N0-vs-N1 |
1.297580E-01 |
| N0-vs-N2 |
5.057400E-01 |
| N1-vs-N2 |
2.716200E-01 |
|
|
